Y. Asahi

Publication List Details

Period

2002 - 2003

Number

16

Co-Authors

com/archive/articles/0103ate.htm (2003)

S. Dey, E. J. Marinissen, Y. Zorian, Test Access Methodology, F. M. Bufler, Y. Asahi, ...

VIII. CONCLUSION In this paper, an efficient implementation of a TAM is proposed for the MSOC testing. The technique introduces I/O access of the analog cores through the MTAM switch, which is...

Comparison of Single-Particle Monte Carlo Simulation with Measured Output Characteristics of an 0.1µm n-MOSFET (2002)

F. M. Bufler, A. Schenk, C. Zechner, N. Inada, Y. Asahi, W. Fichtner

A comparison between non-selfconsistent single-particle Monte Carlo (MC) simulations and measurements of the output characteristics of an 0.1 µm n-MOSFET is presented. First the bulk MC model, which...

In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.

Asahi, Y, Miyazaki, S, Yamaguchi, K

BO-2727, a new injectable carbapenem, was evaluated for its in vitro and in vivo antibacterial activities in comparison with those of biapenem, meropenem, imipenem, cefpirome, and ceftazidime....

Directly repeated insertion of 9-nucleotide sequence detected in penicillin-binding protein 2B gene of penicillin-resistant Streptococcus pneumoniae.

Yamane, A, Nakano, H, Asahi, Y, Ubukata, K, Konno, M

We investigated the molecular mechanism of 50 penicillin-resistant Streptococcus pneumoniae strains (penicillin: MIC, > or = 0.125 microgram/ml) having neither class A nor class B mutations in the...

In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin.

Nakagawa, S, Sanada, M, Matsuda, K, Hashizume, T, Asahi, Y, Ushijima, R, ...

BO-1341, a new antipseudomonal semisynthetic cephalosporin, was evaluated for in vitro and in vivo antibacterial activities in comparison with ceftazidime, cefotaxime, and cefoperazone. The in vitro...

Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.

Kesado, T, Watanabe, K, Asahi, Y, Isono, M, Ueno, K

The susceptibilities of 462 clinical anaerobic bacterial isolates to N-formimidoyl thienamycin and 16 other currently available and investigational antibiotics were determined by the agar dilution...

Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.

Kesado, T, Watanabe, K, Asahi, Y, Isono, M, Ueno, K

The in vitro antibacterial activities of the newly developed 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against 67 clinical isolates of Bacteroides fragilis and...

Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR.

Ubukata, K, Asahi, Y, Yamane, A, Konno, M

PCR was used to identify penicillin resistance in 1,062 clinical isolates of Streptococcus pneumoniae. Three sets of primers were designed to amplify (i) a 240-bp fragment of the penicillin-binding...

Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.

Kesado, T, Hashizume, T, Asahi, Y

The in vitro activity of a new crystalline derivative of thienamycin, N-formimidoyl thienamycin (MK0787), was tested against 46 laboratory reference strains and 2,158 clinical isolates of...

In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.

Asahi, Y, Miyazaki, S, Yamaguchi, K

BO-2727, a new injectable carbapenem, was evaluated for its in vitro and in vivo antibacterial activities in comparison with those of biapenem, meropenem, imipenem, cefpirome, and ceftazidime....

Directly repeated insertion of 9-nucleotide sequence detected in penicillin-binding protein 2B gene of penicillin-resistant Streptococcus pneumoniae.

Yamane, A, Nakano, H, Asahi, Y, Ubukata, K, Konno, M

We investigated the molecular mechanism of 50 penicillin-resistant Streptococcus pneumoniae strains (penicillin: MIC, > or = 0.125 microgram/ml) having neither class A nor class B mutations in the...

In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin.

Nakagawa, S, Sanada, M, Matsuda, K, Hashizume, T, Asahi, Y, Ushijima, R, ...

BO-1341, a new antipseudomonal semisynthetic cephalosporin, was evaluated for in vitro and in vivo antibacterial activities in comparison with ceftazidime, cefotaxime, and cefoperazone. The in vitro...

Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.

Kesado, T, Watanabe, K, Asahi, Y, Isono, M, Ueno, K

The susceptibilities of 462 clinical anaerobic bacterial isolates to N-formimidoyl thienamycin and 16 other currently available and investigational antibiotics were determined by the agar dilution...

Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.

Kesado, T, Watanabe, K, Asahi, Y, Isono, M, Ueno, K

The in vitro antibacterial activities of the newly developed 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against 67 clinical isolates of Bacteroides fragilis and...

Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR.

Ubukata, K, Asahi, Y, Yamane, A, Konno, M

PCR was used to identify penicillin resistance in 1,062 clinical isolates of Streptococcus pneumoniae. Three sets of primers were designed to amplify (i) a 240-bp fragment of the penicillin-binding...

Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.

Kesado, T, Hashizume, T, Asahi, Y

The in vitro activity of a new crystalline derivative of thienamycin, N-formimidoyl thienamycin (MK0787), was tested against 46 laboratory reference strains and 2,158 clinical isolates of...